Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at AMCR's multiple
$10.9874.8% below market
12.37 SUPN revenue / share×0.89x AMCR P/S=$10.98
Market $43.53Implied $10.98
AMCR · current priceP/S 0.89x
$45.15Latest market snapshot
Implied fair value · at SUPN's multiple
$178.93296.3% above market
50.84 AMCR revenue / share×3.52x SUPN P/S=$178.93
Market $45.15Implied $178.93